Skip to Content
Merck
All Photos(1)

Key Documents

View All Documentation

14380C

SAFC

EX-CELL® CD Insect Cell Medium

Chemically defined, sterile-filtered, suitable (for insect cell culture)

Pharma Manufacturing

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

UNSPSC Code:
12352207

Quality Level

500

sterility

sterile-filtered

product line

EX-CELL®

form

liquid

technique(s)

cell culture | insect: suitable

components

NaHCO3: no
L-glutamine: yes

shipped in

ambient

storage temp.

2-8°C

General description

EX-CELL® CD Insect Cell Medium can be used as amplification and production medium for Spodoptera frugiperda (Sf) cells such as Sf21 and Sf9 cells and is compatible with Tni, C636 and S2 cells. The medium has been optimized to get excellent growth and productivity for the rhabdovirus-free Sf-RVN™ Insect Cell Line(Sf9). Together those products form the Sf-RVN™ Platform. The formulation is chemically defined, animal-component free and has been formulated with L-Glutamine.

Legal Information

EX-CELL is a registered trademark of Merck KGaA, Darmstadt, Germany
Sf-RVN is a trademark of Merck KGaA, Darmstadt, Germany

Storage Class Code

12 - Non Combustible Liquids

WGK

WGK 1

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Articles

Can AAV Continue to Deliver the Promise of Gene Therapy?

The current status and future manufacturing of AAV-based gene therapies is discussed in this podcast transcript, including how to streamline large-scale manufacturing.

Can AAV Continue to Deliver the Promise of Gene Therapy?

The current status and future manufacturing of AAV-based gene therapies is discussed in this podcast transcript, including how to streamline large-scale manufacturing.

Can AAV Continue to Deliver the Promise of Gene Therapy?

The current status and future manufacturing of AAV-based gene therapies is discussed in this podcast transcript, including how to streamline large-scale manufacturing.

Cell and Gene Therapy Manufacturing: Upstream Processing for AAV and Lentivirus Platforms

Minimize the complexities of cell and gene therapy production. Switch to upstream viral vector platforms to enhance scalability and simplify GMP manufacturing.

See All

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service